Ticker

No recent analyst price targets found for MBIO.

Latest News for MBIO

Critical Contrast: Mustang Bio (NASDAQ:MBIO) & AstraZeneca (NASDAQ:AZN)

Mustang Bio (NASDAQ: MBIO - Get Free Report) and AstraZeneca (NASDAQ: AZN - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, profitability and analyst recommendations. Analyst Recommendations This is a breakdown of current recommendations

Defense World • Feb 27, 2026
MindBio Announces Private Placement to Raise up to $650,000

Vancouver, British Columbia -  TheNewswire - February 18, 2026  –  MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6); (OTCQB:MBQIF),  (the “ Company ” or “ MindBio ”), a biotechnology company that is commercialising prediction technologies for drug and alcohol intoxication detection using speech analytics and artificial intelligence, is pleased to announce it will conduct a non-brokered private placement (the…

TheNewswire • Feb 18, 2026
MindBio Advances Large-Scale Deployment of Voice Intoxication Detection Through Integrated Edge AI Hardware-Software Platform

Vancouver, British Columbia – TheNewswire - February 18, 2026 – MindBio Therapeutics Corp. (CSE: MBIO) (Frankfurt: WF6) (OTCQB: MBQIF) (“MindBio” or the “Company”) , a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, today announced it has commenced development of a proprietary edge computing platform, including dedicated hardware, to enable large-scale…

TheNewswire • Feb 18, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for MBIO.

No House trades found for MBIO.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top